| Literature DB >> 20940178 |
Robin Liechti1, Gábor Csárdi, Sven Bergmann, Frédéric Schütz, Thierry Sengstag, Sylvia F Boj, Joan-Marc Servitja, Jorge Ferrer, Leentje Van Lommel, Frans Schuit, Sonia Klinger, Bernard Thorens, Najib Naamane, Decio L Eizirik, Lorella Marselli, Marco Bugliani, Piero Marchetti, Stephanie Lucas, Cecilia Holm, C Victor Jongeneel, Ioannis Xenarios.
Abstract
Type 2 diabetes mellitus (T2DM) is a major disease affecting nearly 280 million people worldwide. Whilst the pathophysiological mechanisms leading to disease are poorly understood, dysfunction of the insulin-producing pancreatic beta-cells is key event for disease development. Monitoring the gene expression profiles of pancreatic beta-cells under several genetic or chemical perturbations has shed light on genes and pathways involved in T2DM. The EuroDia database has been established to build a unique collection of gene expression measurements performed on beta-cells of three organisms, namely human, mouse and rat. The Gene Expression Data Analysis Interface (GEDAI) has been developed to support this database. The quality of each dataset is assessed by a series of quality control procedures to detect putative hybridization outliers. The system integrates a web interface to several standard analysis functions from R/Bioconductor to identify differentially expressed genes and pathways. It also allows the combination of multiple experiments performed on different array platforms of the same technology. The design of this system enables each user to rapidly design a custom analysis pipeline and thus produce their own list of genes and pathways. Raw and normalized data can be downloaded for each experiment. The flexible engine of this database (GEDAI) is currently used to handle gene expression data from several laboratory-run projects dealing with different organisms and platforms. Database URL: http://eurodia.vital-it.ch.Entities:
Mesh:
Year: 2010 PMID: 20940178 PMCID: PMC2963318 DOI: 10.1093/database/baq024
Source DB: PubMed Journal: Database (Oxford) ISSN: 1758-0463 Impact factor: 3.451
List of experiments contained in the EuroDia database
| Name | Group | Technology | References |
|---|---|---|---|
| Pancreatic islet implanted transgenic (expressing survivini) in mice | Public | Affymetrix | |
| Beta cells (MIN6) treated with amylin at different times and doses and growth at different concentrations of glucose | Public | Affymetrix | |
| Beta cell specific ablation of Foxa2 (HNF-3b) in mice | Public | Spotted | |
| MIN6 cells treated with Exendin- | Public | Spotted | |
| Pancreas versus islets | Public | Spotted | |
| Transcription profiling of mouse islet growth after partial pancreatectomy and exendin- | Public | Spotted | |
| Mouse islets treated with PANcreatic DERived factor for 48 or 72 h | Public | Spotted | |
| Non-diabetic and diabetic obese mice—islets | Public | Affymetrix | |
| HSL KO and WT | Public | Spotted | |
| Tungstate-induced beta cell mass increase in STZ rats | Public | Affymetrix | |
| Identification of tissue restricted and interferon alpha regulated transcripts in human islet tissue | Public | Affymetrix | |
| LCM human islet beta cells | Public | Affymetrix | |
| Nestin positive cells versus human islets | Public | Affymetrix | |
| Pancreas versus islets | Public | Affymetrix | |
| Human pancreatic islets from normal and type 2 diabetic subjects | Public | Affymetrix | |
| Transcription profiling of HNF4 alpha null mice to investigate the phenotype of dis-regulated insulin secretion and abnormal beta cell growth | Public | Spotted | |
| Cyclophosphamide-induced beta Cell Destruction in NOD Mice | Public | Affymetrix | |
| PPAR gamma overexpression and activation in rat pancreatic islet | Public | Affymetrix | |
| Pancreatic beta cell lines overexpressing wild-type MODY genes or mutant HNF1b alleles | Public | Affymetrix | |
| Islet amyloid polypeptide effect on pancreatic cell line: time course and dose responsed | Public | Affymetrix | |
| Transcription profiling of rat pancreatic islets after culture in low, intermediate and high (glucose) | Public | Affymetrix | |
| Detailed transcriptome atlas of the pancreatic beta cell | Public | Affymetrix | |
| GSIS Study of Rat INS1 cell lines | Public | Spotted | |
| Lipotoxicity Study of Rat INS1 cell lines | Public | Spotted | |
| foxA1 and beta cell function | Public | Spotted | |
| Identification of novel cytokine induced genes in rat pancreatic beta-cells | Eizirik | Affymetrix | ( |
| Global profiling of double stranded RNA- and IFN-gamma-induced genes in rat pancreatic beta cells | Eizirik | Affymetrix | ( |
| Cytokine-induced and nuclear factor-kappa B-dependent genes in primary rat beta-cells | Eizirik | Affymetrix | ( |
| Global gene expression profiling in cytokine-treated rat pancreatic beta-cells | Eizirik | Affymetrix | ( |
| Global alternative splicing profiling in cytokine-treated rat pancreatic beta-cells | Eizirik | Affymetrix | ( |
| Gene expression differences between control and Tcf1/Hnf1alpha knock-out pancreatic islets | Ferrer | Affymetrix | ( |
| Gene expression differences between control, Pancreas-specific Hnf4alpha knock-out(P-Hnf4aKO, mediated by expression of Pdx-1Cre transgen),Tcf1/Hnf1alpha heterozygous (Hnf1aHET) and double mutant (P-Hnf4a;Hnf1aHET) pancreatic islets | Ferrer | Affymetrix | ( |
| Gene expression data from murine islet samples comparing transgenic mice with beta cell specific hormone sensitive lipase (HSL) overexpression with wild-type mice | Holm | Affymetrix | |
| Calcineurin inhibitors on human islets | Marchetti | Affymetrix | ( |
| Type 2 diabetic versus non-diabetic islets | Marchetti | Affymetrix | |
| Beta cells of type 2 diabetic subjects versus beta cells of non-diabetic controls | Marchetti | Affymetrix | ( |
| Islet S/A LF versus HF diet | Schuit | Affymetrix | ( |
| Islet WT versus islets S/A control diet | Schuit | Affymetrix | ( |
| HF-diet versus normal diet in islets of WT C57Bl6 mice | Schuit | Affymetrix | |
| Time-course HFD study in WT mice | Schuit | Affymetrix | |
| Double GIP-R + GLP1-R KO mice—pancreatic islets | Thorens | Spotted | ( |
| Comparison GLP-1 or GLP-1+diazoxide treatment of betaTcTet cells for 7h. Pancreatic beta cell line | Thorens | Spotted | |
| Treatment of betaTcTet cells with GLP-1 (Glucagon-like peptide 1) for 0, 45 min, 3 h and 7 h | Thorens | Spotted | ( |
| Direct comparison of GLP-1 and GIP treatment for 7 h on betaTcTet— Pancreatic beta cell line | Thorens | Spotted |
HSL: hormone sensitive lipase, KO: knock-out, WT: wild-type, LCM: laser capture microdissection, GSIS: glucose stimulated insulin secretion, S/A: eIF2-Ser51 is mutated to encode an alanine, LF: low fat, HF: high fat, HFD: high fat diet.
Figure 1.Web interface. (A) Experiments can be grouped by type, laboratory affiliation, project, organism or array design. For each category, experiment name and description are presented. Clicking on one experiment name reveals quality control plots (B) and the list of related hybridizations. (C) For each hybridization, quality control plots are provided. (D) Experiments can be downloaded in three forms: normalized data with probe annotation, raw data and Bioconductor expressionSet object.
Figure 2.Experiment analysis. The order of the boxes reflects the flow of analysis steps. From top to bottom and left to right, the experiment name and description, the selection of the type of analysis, the form to describe analysis design (for this example, paired samples design), the list of differentially expressed probes with their relevant gene symbol, expression ratios and P-values of differential expression and the list of altered GO categories is provided.